Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I sold most of my NWBO and bought bitcoin in feb, has been the best decision for me.
Am closing out the rest today, stocks cap is 25m, this is done
Anyone who thinks this stock is a "buy" at this point is insanely delusional.
Big pharma execs would rather spend billions on a sure thing rather than tens/hundreds of millions on a gamble.
If a small time multi million dollar gamble went south, theyll easily be in the dog house or fired...versus buying into a up and coming bio who just had a positive p3 readout
A lot of analysts based their p3 projections of the dfs events based on the neuvax p2 info. Their event hit much later than expected, which made people very optimistic
Also, gale had a cap at around 250m before the p3 readout
I bought in a small position into NWBO but its very risky and the price action shows it.
Look into GALE and their p3.
Tons of people posted up the "math" to say that the p3 was a slam dunk. Problem was that their p2 data was flawed and it threw off their p3 projections
DNDN had cost, manufacturing and logistics issues with its provenge.
Any idea where NWBOs treatment stands? Is it insanely pricey and difficult to manufacture?
I took a small position in NWBO based off of charts and P3 readouts, i have obviously not done much DD haha
Reading too much into the tea leaves
No sure thing, especially NWBO. We are where we are for good reason, purely speculative and very high risk attached.
Ive been in a lot of biotechs and the good and bad, in hindsight, are unpredictable
Insider buying and holding seems to be the difference in these guys but even that isnt a guarantee
GLTA
Ive been in and out of a number of different p3 bios.
A few things ive learned:
-theyre all crapshoots, anyone who tells you of "a sure thing" is full of shit
- avoid advice from overzealous number crunchers
- do not read into the tea leaves
- do not be overly optimistic or confident
- dont fall in love. Set entry and exit points. If it rallies further after you sold, dont dwell. If it rallies past your target, avoid pie in he sky delusions and sell. If you take a beating, sell and move on. Do not dwell.
- play with money you can afford to lose
- do not fall in love
Thanks for that.
Bought in for a swing trade and am hoping this was oversold and a bounce back will happen.
Will keep outlook in mind.
Always a fun gamble playing the P3 news
Glta
I scanned various forums and saw "any day" being tossed around. Have the dfs events been met? Also read that the november estimated date was being reviewed and that a read out of blinded data should be happening "soon"?
When is the P3 readout to occur?
Im new to the stock and just bought in
Thanks in advance
Havent followed innv for a while.
Any news on fluticare?
What will happen to the application if its not approved in calendar year 2016?
Does it get pushed back (yet again)?
When is the FDA approval window?
I stopped following this and september has come and gone.
What is the new window for approval or dismissal?
Exactly.
No such thing as a sure bet
Carlos, welcome to the wonderful world of investing. Its going to be a very expensive education. You win some and lose others.
A lot of these $1+ predictions could be true if they receive fda approval and also their sales ramp.
There are basic rules of thumb to get ballpark ranges of pps. This has to with earnings vs multipliers and debt.
The recent bullish move of them paying off some debt is also adding to the value
PSA - Yahoo message boards FUBAR
Which explains why we are getting more traffic / trolls here
607k shares in the first 15 minutes... Wow
If approval happened and insiders are buying in advance, that is very illegal
We have fda decision coming sometime between now and end of sept.
No point doing a rs unless we get denies
Exciting times indeed
Interesting to see where could be with fda approval
Will definitely get uplisting as well
Whoops, just realized i wrote on the wrong board... Sorry, meant that message for another board
Nvm i thought it was something else eom
What presentation? Eom
Sugar,
I know the dilemma. I missed out on the single digits because of cold feet.
I think the gains over the last few weeks are somewhat real.
Now we wait for the fda
Assuming we get the 30-90m target, that could put pps at around 4-12
Though global sales would take 4years to realize, according to damaj
He thinks someone would buy us out by then
Damaj said it himself in an interview that he is targeting 30m in sales in the US And 90m globally
That is huge and realistic
Carlos! I saw your post on yahoo message boards, my handle is cumon4343
I hope im wrong, doubtful to see $4 until first few quarters of sales are in the books.
If we have decent sales first quarter, our second quarter becomes a big deal, to see what % growth and speed etc.
Obviously, none of this means squat without fda approval
Huge volume play, very bullish move
Lots of bullish moves recently
Still a crapshoot but good to see the gains. Anyone else locking in? Or riding till fda?
I posted an article earlier on the big boys getting 100m in their first year...no way in hell do we come close to that...if we can get 20-30m, that would be good
Their pipeline outside of fluticare is garbage. Its all fluticare or not.
If they get approval, they can get this in stores much more easily than feminine lube and herbal supplements
Nice to see the gains? Anyone taking profits off the table or riding with it?
Thanks for the clarity, didnt realize there was a merger.
Good to see that the warrants were exercised.
Has a lot to do with insiders buying last week. It set a floor and some confidence
Still a crap shoot but am hoping Dr. D still knows his way around the rodeo
The ingredients are one thing... The manufacturing, distribution and follow up are the other thing.
Fda will decide on complete package
Relax guys, even if we see .30s
I welcome the .30s..
Our pipeline and lead candidate are all in p2
TPIV will be painfully slow between now and p2 readouts and finish
Gale was out biggest competition and they "possibly" failed their p3 midpoint
Dr damaj is very methodical
Has laid the groundwork to push fluticare, assuming approval.
I just bought in some more this morning and will wait.
None of this matters without fda approval
So proceed with caution
Pie in the sky prediction...
Fluticare WILL NOT reach 1 billion annual sales.
That 1b figure was pulled from their press release where they said they BELIEVE the market for otc for fluticasone was 1b.
We dont have the distribution and marketing in place to capture that large of a sales figure.
Read attached article... The big boys have their own products and it shows their sales/market penetration.
If you think for a second we are getting figures near those levels, youre out of your mind.
http://www.klinegroup.com/blogs/index.php/2015/09/03/top-three-drivers-of-the-u-s-otc-market/
I agree with your caution..."sure things" never exist...especially to us retailers.
I do like the risk reward here though but the need to proceed with caution is obvious.
If we dont get fda approval, this will tank back down to a nickel